Home › Compare › Retatrutide vs Survodutide
Retatrutide vs Survodutide
Side by side, in plain English — what each one is, where they overlap and where they genuinely differ.
At a glance
| Retatrutide | Survodutide | |
|---|---|---|
| Category | Metabolic / Weight Loss | Metabolic / Weight Loss |
| Typical route | SubQ | SubQ |
| Shelf life once mixed | ~30 days | ~30 days |
| Commonly reported effects | Extreme fat loss Increased energy expenditure Metabolic reset | Fat loss Increased metabolic rate Appetite suppression |
| Reported considerations | Severe GI distress if titrated fast Elevated heart rate | Nausea GI distress |
The differences that actually matter
Both are classed as Metabolic / Weight Loss peptides, so they get compared constantly and are often researched for overlapping reasons.
Where they overlap: extreme fat loss, metabolic reset.
Reported mainly for Retatrutide: increased energy expenditure.
Reported mainly for Survodutide: appetite suppression.
What Retatrutide is
Retatrutide is an investigational peptide that operates as a triple agonist, targeting the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. By activating these three distinct receptors, retatrutide is understood to influence multiple metabolic pathways, including glucose regulation, appetite control, and energy expenditure. The activation of GLP-1 and GIP receptors generally promotes glucose-dependent insulin secretion and slows gastric emptying, while glu
What Survodutide is
Survodutide is a peptide designed to function as a dual agonist for both the glucagon-like peptide-1 (GLP-1) and glucagon receptors. By activating GLP-1 receptors, it is understood to reduce appetite, slow gastric emptying, and enhance glucose-dependent insulin secretion, contributing to improved blood sugar regulation and feelings of fullness. Concurrently, its action on glucagon receptors is intended to increase energy expenditure and stimulate lipolysis, which is the breakdown of stored fats. This combined agoni
How to compare them for yourself
Anecdotes online are noisy because nobody is measuring the same thing. The only comparison that means anything is your own: log each entry with a timestamp, keep the vial ledger honest so you know what you actually got through, pick two or three metrics before you start, and look at the trend after several weeks rather than day to day.
Peptide Wizard does that part for you — Retatrutide and Survodutide are both in the built-in reference library with a 3D vial, and your history, vial ledger and cost per entry stay private on your device.
FAQ
What is the difference between Retatrutide and Survodutide?
Both are classed as Metabolic / Weight Loss peptides, so they get compared constantly and are often researched for overlapping reasons.
Can you log Retatrutide and Survodutide in the same period?
Plenty of people record more than one peptide at a time. Peptide Wizard keeps a separate vial ledger and entry history for each, so you can see exactly what overlapped and when — it does not recommend combinations or doses.
Which is better, Retatrutide or Survodutide?
There isn't a universal answer — reported responses vary a lot between individuals, which is why your own log is more informative than anyone else's anecdote. Track one variable at a time and compare your own metrics over several weeks.
Is this medical advice?
No. This page is educational reference material only. It contains no dosing guidance. Speak to a qualified healthcare professional before making any decisions.
See all peptide comparisons →
Educational reference only. This page contains no dosing guidance and is not medical advice.
RetatrutideMetabolic / Weight Loss
SurvodutideMetabolic / Weight Loss